Donna Krupa
(301) 634-7209
dkrupa@the-aps.org
Nicotine: The Link Between Cigarette Smoking and Kidney Disease Progression?
(BETHESDA, MD) -- Cigarette smoke (CS) is the most preventable cause of death and chronic disease in the United States. In addition to being a risk factor for atherosclerosis and cancer, recent epidemiologic studies suggest that cigarette smoke promotes the progression of kidney disease.
The mechanisms by which cigarette smoke may accelerate some types of chronic kidney disease are currently unknown. A new study, being published by the American Physiological Society (http://www.the-aps.org/), demonstrates for the first time that human mesangial cells (MC) – cells in the blood vessels of the kidneys – are endowed with nicotinic receptors (nAChRs) α4, α5, α7, β2, β3, β4 and β5 (cells that interact with the nicotine in tobacco) and may play an active role in the development of certain kidney diseases.
The Study
The study, “Nicotine: The Link Between Cigarette Smoking and the Progression of Renal Injury?,” was conducted by Edgar A. Jaimes, MD, Run-Xia Tian, MD, and Leopoldo Raij, MD, all of the Miller School of Medicine, University of Miami, Miami, FL. It appears in the Articles in Press Section of the American Journal of Physiology – Heart and Circulatory Physiology (http://ajpheart.physiology.org/), one of 11-peer reviewed journals published by the APS.
Overview of Methodology
Human mesangial cells were grown in CSC-Complete media, supplemented with 10 percent fetal calf serum. Cells were passed by trypsinization when confluent and used between the third and ninth passages. 3H-thymidine was used as an index of cell proliferation and cells were fasted for 72 hours in Maintenance Media and stimulated for 24 hours with nicotine (10-10 M to 10-7 M) or platelet derived growth factor.
Western blots were performed after the cells fasted and had been stimulated for 24 hours with nicotine (10-7). Cell homogenates were washed and thereafter centrifuged for 30 minutes. Blots were incubated overnight with one of nine antibodies, which included mouse anti-α2-nAChR mAb’s, anti-α3-nAChR mAb’s, or anti-α4-nAChR mAb’s. Fibronectin mRNA expression was determined by real time PCR and protein expression was measured by western blot. Flow cytometry measurement was generated for reactive oxygen species.
Data were expressed as mean ± SEM. For statistical comparisons involving two groups, an unpaired Student t test was used. For comparisons involving more than two groups, ANOVA was used. Significance was considered when P<0.05.
Highlights of Results
Highlights of the results include the following:
Human mesangial cells express nAChRs: The researchers were able to detect strong expression of several nAChRs subunits in the cultured human mesangial cells. They detected the presence of the nAChRs subunits α4, α5, α7, β2, β3, and β4 in these cells. They were not, however, able to detect significant expression of the α2 or α3 nAChR subunits.
Nicotine increases mesangial cell proliferation via nAChRs activation: Nicotine stimulation of the cells resulted in a dose dependent increase in mesangial cell proliferation. One concentration found in the plasma of active smokers found that nicotine-induced MC proliferation was 1,328 for controls vs. 2,761 for nicotine.
Nicotine increases fibronectin production: To determine whether transcriptional mechanisms were involved, the researchers measured the gene expression of fibronectin using real time exposure to nicotine. They found that nicotine induced a five-fold increase in fibronectin mRNA expression.
Summary and Conclusions
These studies are believed to be the first of their kind to:
(1) identify the presence of functionally active nAChRs in human mesangial cells; and
(2) demonstrate that nicotine, at concentrations similar to those found in the plasma of smokers, promotes mesangial cell proliferation and spurs on critical molecules that are involved in the extracellular matrix production.
Recent epidemiologic studies demonstrate that cigarette smoking increases the risk for progressive chronic kidney disease, but the role of smoking in primary renal diseases is less known. The results of this research, coupled with earlier findings, reveal previously unrecognized mechanisms showing nicotine – a component of cigarette smoke – as an agent that may accelerate and promote the progression of chronic kidney disease.
***
JOURNAL PUBLICATION INFORMATION
American Journal of Physiology – Heart and Circulatory Physiology, (Articles in Press) http://ajpheart.physiology.org/.
Physiology is the study of how molecules, cells, tissues and organs function to create health or disease. The American Physiological Society (APS) has been an integral part of this scientific discovery process since it was established in 1887.
Chromium Picolinate May Lessen Inflammation in Diabetic Nephropathy
Released September 22, 2010 - Taking chromium picolinate may help lessen inflammation associated with kidney disease is the conclusion of a study comparing diabetic mice treated with chromium picolinate with those that received placebo. Mice who received the supplement had lower levels of albuminuria (protein in the urine), an indication of kidney disease. Untreated diabetic mice had marked immunostaining for interleukin 6 (IL-6) and interleukin 17 (IL-1 and moderate immunostaining for indolamine 2,3-dioxygenase (IDO), an immunoregulatory enzyme that modulates the production of IL-6 and IL-17.
Prenatal Nicotine Exposure Can Lead To Cardiac Function Reprogramming as Adults
Released May 1, 2007 - At least 11 percent of American women smoke during pregnancy. Now, a new study using an animal model, provides strong evidence that the effects of maternal smoking during the prenatal period of life can lead to cardiac vascular dysfunction beyond the formative years and into adulthood.
Female Gender Provides An Advantage In Renal Diseases
Released August 8, 2007 - Sex hormones (estrogen, testosterone) are thought to contribute to health differences, as hormones may influence the body’s responses to renal injury. Estrogen especially may exert certain cellular effects on the kidney because it can suppress the growth of scar tissue as well as affect various growth factors which impact the kidney.
Is Testosterone Replacement Therapy Safe For Aging Men?
Released August 8, 2007 - For decades, older women have taken hormone replacements to replenish estrogen and progesterone levels lost to aging. More recently, testosterone (the most important male hormone) supplements have been used by aging men to improve their muscle mass, bone strength, libido and quality of life. The increased use has occurred despite the fact that the cardiovascular effects of chronic testosterone treatment in aging males are largely unknown, and the safety of testosterone replacement has not been evaluated. Researchers are using an animal model to examine potential links between testosterone supplements, and cardiovascular and renal disease.
Estrogen Deficiency Can Lead To Obesity-Induced Hight BP After Menopause
Released August 8, 2007 - At menopause, women lose hormone protection against heart (cardiovascular) and kidney diseases, and are likely to become obese. A research team has tested the idea that estrogen deficiency in aged females may trigger the development of high blood pressure and obesity. The results of their study, using an animal model, suggest that estrogen depletion can have these effects.